Actinobacillus actinomycetemcomitans Y4 capsular polysaccharide induces IL-1β mRNA expression through the JNK pathway in differentiated THP-1 cells

Clinical and Experimental Immunology

Volumn 141, Issue 2, 2005, Pages 261-269

  Iwata, T ^a   Mitani, A ^a   Ishihara, Yuichi ^a   Tanaka, S ^a   Yamamoto, G ^a   Kikuchi, T ^a   Naganawa, T ^a   Matsumura, Y ^a   Suga, T ^a   Koide, M ^a   Sobue, T ^a   Suzuki, T ^a   Noguchi, T ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Actinobacillus actinomycetemcomitans; IL 1; JNK; Macrophage

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BACTERIAL POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE; CYTOKINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIODONTITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; BACTERIAL CAPSULES; CELL DIFFERENTIATION; CELL LINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 22344454362     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02836.x     Document Type: Article

References (62)

1. Zambon JJ, Christersson LA, Slots J. Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotype within families. J Periodontol 1983; 54:707-11.
2. Zambon JJ, Christersson LA, Genco RJ. Diagnosis and treatment of localized juvenile periodontitis. J Am Dent Assoc 1986; 113:295-9.
3. Haapasalo M, Ranta H, Ranta K, Shah H. Black-pigmented Bacteroides spp. in human apical periodontitis. Infect Immun 1986; 53:149-53.
4. Slots J. Bacterial specificity in adult periodontitis: a summary of recent work. J Clin Periodontol 1986; 13:912-7.
5. Slots J, Genco RJ. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease, virulence factors in colonization, survival, and tissue destruction. J Dent Res 1984; 63:412-21.
6. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985; 12:1-20.
7. Taichman NS, Dean RT, Sanderson CJ. Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans. Infect Immun 1980; 28:258-68.
8. Tsai CC, Shenker BJ, DiRienzo JM, Malamud D, Taichman NS. Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B. Infect Immun 1984; 43:700-5.
9. Iino Y, Hopps RM. The bone-resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Capnocytophaga ochracea isolated from human mouths. Arch Oral Biol 1984; 29:59-63.
10. Kiley P, Holt SC. Characterization of the lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4 and N27. Infect Immun 1980; 30:862-73.
11. Wilson M, Kamin S, Harvey W. Bone resorbing activity of purified capsular material from Actinobacillus actinomycetemcomitans. J Periodontal Res 1985; 20:484-91.
12. Amano K, Nishihara T, Shibuya N, Noguchi T, Koga T. Immunochemical and structural characterization of a serotype-specific polysaccharide antigen from Actinobacillus actinomycetemcomitans Y4 (serotype b). Infect Immun 1989; 57:2942-6.
13. Takahashi T, Nishihara T, Ishihara Y et al. Murine macrophage interleukin-1 release by capsular-like serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans. Infect Immun 1991; 59:18-23.
14. Ueda N, Nishihara T, Ishihara Y, Amano K, Kuroyanagi T, Noguchi T. Role of prostaglandin in the formation of osteoclasts induced by capsular-like polysaccharide antigen of Actinobacillus actinomycetemcomitans strain Y4. Oral Microbiol Immunol 1995; 10:69-75.
15. Nishihara T, Ueda N, Amano K et al. Actinobacillus actinomycetemcomitans Y4 capsular-polysaccharide-like polysaccharide promotes osteoclast-like cell formation by interleukin-1 alpha production in mouse marrow cultures. Infect Immun 1995; 63:1893-8.
16. Yuko O, Yuichi I, Masahiro O. Capsular polysaccharide from Actinobacillus actinomycetemcomitans inhibits IL-6 and IL-8 production in human gingival fibroblast. J Periodontal Res 2003; 38:191-7.
17. Weinstein SL, Gold MR, DeFranco AL. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 1991; 88:4148-52.
18. Fenton MI, Golenbock DT. LPS-binding proteins and receptors. J Leukoc Biol 1998; 64:25-32.
19. Geppert TD, Whitehurst CE, Thompson P, Beutler B. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol Med 1994; 1:93-103.
20. Gray JG, Chandra G, Clay WC et al. A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 beta gene is necessary for induction in U937 and THP-1 monocytic cell lines. Mol Cell Biol 1993; 13:6678-89.
21. 3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. J Immunol 1992; 149:2040-6.
22. Nishihara T, Koga T, Hamada S. Suppression of murine macrophage interleukin-1 release by the polysaccharide portion of Haemophilus actinomycetemcomitans lipopolysaccharide. Infect Immun 1988; 56:619-25.
23. Rantz LA, Randall E. Use of autoclaved extracts of hemolytic streptococci for serological grouping. Stanford Med Bull 1955; 13:290-1.
24. Feghali C, Wright T. Cytokines in acute and chronic inflammation. Front Biosci 1997; 2: d12-26.
25. Jacobs J, Roebuck K, Archibeck M, Hallab N, Giant T. Osteolysis: Basic science. Clin Orthop 2001; 393:71-7.
26. Ridderstad A, Abedi-Valugerdi M, Moller E. Cytokines in rheumatoid arthritis. Ann Med 1991; 23:219-23.
27. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-147.
28. Stashenko P, Dewhirst F, Peros W, Kent RL, Ago J. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987; 138:1464-8.
29. Amin A, Dave M, Attur M, Abramson S. COX-2, NO, and cartilage damage and repair. Curr Rheumatol Rep 2000; 2:447-53.
30. Ishihara Y, Nishihara T, Kuroyanagi T et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodont Res 1997; 32:524-9.
31. Charon JA, Luger TA, Mergenhagen SE, Oppenheim JJ. Increased thymocyte-activating factor in human gingival fluid during gingival inflammation. Infect Immun 1982; 38:1190-5.
32. Mergenhagen SE. Thymocyte activating factor(s) in human gingival fluids. J Dent Res 1984; 63:461-4.
33. Kobashima H, Maeda K, Iwamoto Y et al. Partial characterization of an interleukin-1-like factor in human gingival crevicular fluid from patients with chronic inflammatory periodontal disease. Infect Immun 1990; 58:2621-7.
34. Matsuki Y, Yamamoto T, Hara K. Localization of interleukin-1 (IL-1) mRNA-expressing macrophages in human inflamed gingival and IL-1 activity in gingival crevicular fluid. J Periodont Res 1993; 28:35-42.
35. Curtis DA, Kao R, Plesh O, Finzen F, Franz L. Crevicular fluid analysis around two failing dental implants: a clinical report. J Prosthodont 1997; 6:210-4.
36. Tsai C-C, Ho Y-P, Chen C-C. Levels of interleukin-1 and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 1995; 66:852-9.
37. Salvi GE, Yalda B, Collins JG et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997; 68:127-5.
38. Gonzales JR, Herrmann JM, Boedeker RH, Francz PI, Biesalski H, Meyle J. Concentration of interleukin-1beta and neutrophil elastase activity in gingival crevicular fluid during experimental gingivitis. J Clin Periodontol 2001; 28:544-9.
39. Kinane DF, Winstanley FP, Adonogianaki E, Moughal NA. Bioassay of interleukin 1 (IL-1) in human gingival crevicular fluid during experimental gingivitis. Arch Oral Biol 1992; 37:153-6.
40. Ishihara Y, Nishihara T, Maki E, Noguchi T, Koga T. Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. J Periodont Res 1991; 26:155-60.
41. 2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. J Periodont Res 1998; 33:509-16.
42. Agarwal S, Piesco NP, Johns LP, Riccelli AE. Differential expression of IL-1 beta, TNF-alpha, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J Dent Res 1995; 74:1057-65.
43. Kent LW, Rahemtulla F, Hockett RD Jr, Gilleland RC, Michalek SM. Effect of lipopolysaccharide and inflammatory cytokines on interleukin-6 production by healthy human gingival fibroblasts. Infect Immun 1998; 66:608-14.
44. Galdiero M, Isonto MD, Vitello M, Finamore E, Peluso L, Galdiero M. Porins from Salmonella enterica serovar Typhimurium induce TNF-α, IL-6 and IL-8 release by CD14-independent and CD11a/CD18-dependent mechanisms. Microbiology 2001; 147:2697-704.
45. Kelk P, Claesson R, Hanstrom L, Lerner UH, Kalfas S, Johansson A. Abundant secretion of bioactive interleukin-1β by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2005; 73:453-8.
46. Naganuma K, Amano S, Takeda H, Kitano S, Hanazawa S. Role of transcriptional factor activation protein-1 in endogenous expression of the interleukin-1 beta gene involved in Porphyromonas gingivalis fimbria-stimulated bone resorption in the mouse calvarial system. Oral Microbiol Immunol 2000; 15:53-7.
47. Nishida E, Hara Y, Kaneko T, Ikeda Y, Ukai T, Kato I. Bone resorption and local interleukin-1alpha and interleukin-1beta synthesis induced by Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res 2001; 36:1-8.
48. Schytte Blix IJ, Helgeland K, Hvattum E, Lyberg T. Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates production of interleukin-1beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagonist in human whole blood. J Periodontal Res 1999; 34:34-40.
49. Carter AB, Monick MM, Hunninghake GW. Both Erk and p38 kinases are necessary for cytokine gene transcription. Cell Mol Biol 1999; 20:751-8.
50. 2 production in lipopolysaccharide-stimulated monocytes. J Immunol 1998; 161:5681-6.
51. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270:7420-6.
52. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 1994; 269:26546-51.
53. Devary Y, Gottlieb RA, Lau LF, Karin M. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. Mol Cell Biol 1991; 11:2804-11.
54. Binetruy B, Smeal T, Karin M. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 1991; 351:122-7.
55. Hambleton J, Weinstein SL, Lem L, DeFranco AL. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 1996; 93:2774-8.
56. Reimann T, Buscher D, Hipskind RA, Krautwald S, Lohmann-Matthes ML, Baccarini M. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and the TNF-alpha genes. J Immunol 1994; 153:5740-9.
57. Geng Y, Valbracht J, Lotz M. Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest 1996; 98:2425-30.
58. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265:808-11.
59. Lee JC, Laydon JT, McDonnell PC et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739-46.
60. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997; 9:240-6.
61. Swantek JL, Cobb MH, Geppert TD. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol Cell Biol 1997; 17:6274-82.
62. Yamamoto S, Mogi M, Kinpara K et al. Anti-proliferative capsular-like polysaccharide antigen from Actinobacillus actinomycetemcomitans induces apoptotic cell death in mouse osteoblastic MC3T3-E1 cells. J Dent Res 1999; 78:1230-7.